Delivery Order SPE2DB24D2212-SPE2DB24FHNCV
Award Date
7/25/24
Potential Completion Date
7/26/24
Potential Value
$12K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,914.83 delivery order contract is for the supply of 4,566,188,517 units of 8 mg Ondansetron HCL tablets, with a period of performance ending on October 24, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $12,884.53 firm fixed-price contract covers the delivery of 4,567,198,399 units of Ondansetron HCL 8 mg tablets to support military healthcare programs. The contract has a completion date of February 7, 2025 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $4,695.84, is for the delivery of 4,563,755,984 tablets of Ondansetron HCL 8 mg. The contract is a Firm Fixed Price Delivery Order with a completion date of February 26, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,903.20 contract is for the delivery of Ondansetron HCL 8 mg tablets. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which provides a comprehensive global pharmaceutical support vehicle through December...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,817.62 Firm Fixed Price Delivery Order is for the supply of 4,563,265,608 units of Ondansetron HCL 8 mg Tablets in 30-count packages. The contract has a period of performance through January 9, 2024 and does not include any set-aside designation. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,087.08 firm fixed-price delivery order is for the supply of 4,563,680,292 units of 8 mg Ondansetron HCL tablets. The contract has an ultimate completion date of February 16, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,589.89 firm fixed-price delivery order is for the provision of 4,567,437,179 units of Ondansetron HCL 8 mg tablets. The contract has an ultimate completion date of March 4, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was granted by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order valued at $4,733.59 for the supply of 4,566,262,385 units of Ondansetron HCL 8 mg tablets. The contract has an ultimate completion date of October 30, 2024 and is a firm fixed-price arrangement. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,395.46 firm fixed-price delivery order is for the supply of 4565153915 - Ondansetron HCl 8 mg Tablets, 30s. The contract has a completion date of July 16, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical that serves as a primary...
This federal contract award by the Defense Logistics Agency (DLA) is a Delivery Order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of 4 mg Ondansetron HCl tablets. The $9,937.88 Firm Fixed Price contract has a completion date of January 14, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...